Sera Prognostics (SERA) Competitors $2.92 -0.08 (-2.67%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$2.92 0.00 (0.00%) As of 07/18/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SERA vs. EHAB, AIRS, TOI, VMD, XGN, DCGO, EUDA, CORBF, QIPT, and KDLYShould you be buying Sera Prognostics stock or one of its competitors? The main competitors of Sera Prognostics include Enhabit (EHAB), AirSculpt Technologies (AIRS), Oncology Institute (TOI), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), EUDA Health (EUDA), Global Cord Blood (CORBF), Quipt Home Medical (QIPT), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry. Sera Prognostics vs. Its Competitors Enhabit AirSculpt Technologies Oncology Institute Viemed Healthcare Exagen DocGo EUDA Health Global Cord Blood Quipt Home Medical Kindly MD Sera Prognostics (NASDAQ:SERA) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation. Is SERA or EHAB more profitable? Enhabit has a net margin of -13.43% compared to Sera Prognostics' net margin of -28,685.22%. Enhabit's return on equity of 2.02% beat Sera Prognostics' return on equity.Company Net Margins Return on Equity Return on Assets Sera Prognostics-28,685.22% -51.35% -37.21% Enhabit -13.43%2.02%0.94% Which has more risk & volatility, SERA or EHAB? Sera Prognostics has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.72, suggesting that its share price is 72% more volatile than the S&P 500. Do analysts recommend SERA or EHAB? Enhabit has a consensus target price of $8.75, indicating a potential upside of 28.87%. Given Enhabit's stronger consensus rating and higher probable upside, analysts clearly believe Enhabit is more favorable than Sera Prognostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sera Prognostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Enhabit 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders & institutionals believe in SERA or EHAB? 54.6% of Sera Prognostics shares are held by institutional investors. 13.5% of Sera Prognostics shares are held by company insiders. Comparatively, 3.4% of Enhabit shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, SERA or EHAB? Sera Prognostics has higher earnings, but lower revenue than Enhabit. Sera Prognostics is trading at a lower price-to-earnings ratio than Enhabit, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSera Prognostics$80K1,374.96-$32.90M-$0.94-3.11Enhabit$1.03B0.33-$156.20M-$2.77-2.45 Does the media favor SERA or EHAB? In the previous week, Enhabit had 3 more articles in the media than Sera Prognostics. MarketBeat recorded 3 mentions for Enhabit and 0 mentions for Sera Prognostics. Enhabit's average media sentiment score of 0.97 beat Sera Prognostics' score of 0.00 indicating that Enhabit is being referred to more favorably in the news media. Company Overall Sentiment Sera Prognostics Neutral Enhabit Positive SummaryEnhabit beats Sera Prognostics on 11 of the 16 factors compared between the two stocks. Get Sera Prognostics News Delivered to You Automatically Sign up to receive the latest news and ratings for SERA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SERA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SERA vs. The Competition Export to ExcelMetricSera PrognosticsMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$113.02M$6.98B$5.55B$9.40BDividend YieldN/A2.88%3.75%4.03%P/E Ratio-3.1126.7928.0119.82Price / Sales1,374.9636.65432.8198.20Price / CashN/A28.0836.1658.27Price / Book2.099.018.125.65Net Income-$32.90M$233.10M$3.25B$257.91M7 Day Performance2.82%-0.15%1.68%3.38%1 Month Performance55.32%1.22%7.30%11.11%1 Year Performance-62.56%23.63%32.89%18.99% Sera Prognostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SERASera Prognostics0.2379 of 5 stars$2.92-2.7%N/A-63.0%$113.02M$80K-3.11120EHABEnhabit3.4262 of 5 stars$7.05+0.1%$8.75+24.0%-27.6%$357.19M$1.03B-2.5510,700News CoverageHigh Trading VolumeAIRSAirSculpt Technologies1.2891 of 5 stars$5.24+5.2%$3.75-28.4%+21.4%$308.01M$172.10M-17.47240High Trading VolumeTOIOncology Institute2.2268 of 5 stars$3.21+2.6%$7.00+118.1%+573.1%$286.44M$403.15M-4.59660News CoverageAnalyst UpgradeAnalyst RevisionHigh Trading VolumeVMDViemed Healthcare0.9548 of 5 stars$6.72-0.3%N/A-8.5%$265.57M$224.26M22.401,179XGNExagen3.1439 of 5 stars$7.07+1.1%$7.50+6.1%+262.7%$150.59M$56.72M-8.42220News CoverageHigh Trading VolumeDCGODocGo1.9002 of 5 stars$1.46-2.0%$3.56+143.8%-55.5%$148.90M$520.50M-73.004,407EUDAEUDA Health1.2734 of 5 stars$3.29-0.3%N/A-19.8%$122.24M$4.01M0.002News CoveragePositive NewsCORBFGlobal Cord BloodN/A$0.75flatN/A-54.2%$91.16M$196.12M0.001,200Gap DownQIPTQuipt Home Medical2.8245 of 5 stars$1.90+1.6%$2.85+50.0%-38.2%$82.54M$240.85M-9.051,200KDLYKindly MDN/A$12.30-7.5%N/A+309.7%$74.07M$2.47M-15.97N/ANews CoveragePositive News Related Companies and Tools Related Companies EHAB Competitors AIRS Competitors TOI Competitors VMD Competitors XGN Competitors DCGO Competitors EUDA Competitors CORBF Competitors QIPT Competitors KDLY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SERA) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sera Prognostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sera Prognostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SERA Stock Alerts